$AFCG
Advanced Flower Capital Inc.

2023 Q2 Form 10-Q Financial Statement

#000182252323000012 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $16.10M $16.83M $17.39M
YoY Change -19.12% -3.18% 271.09%
Cost Of Revenue $3.313M $3.704M $3.847M
YoY Change -21.14% -3.72% 337.18%
Gross Profit $12.79M $13.10M $13.54M
YoY Change -18.57% -3.23% 255.34%
Gross Profit Margin 79.42% 77.84% 77.87%
Selling, General & Admin $1.626M $2.708M $2.534M
YoY Change 2.4% 6.86% 15.17%
% of Gross Profit 12.72% 20.67% 18.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.940M $6.412M $6.381M
YoY Change -14.68% 0.48% 107.6%
Operating Profit $7.846M $6.690M $7.157M
YoY Change -20.85% -6.53% 872.15%
Interest Expense $1.576M $1.668M $1.700M
YoY Change -9.8% -1.88%
% of Operating Profit 20.08% 24.94% 23.75%
Other Income/Expense, Net $1.606M -$702.4K -$905.1K
YoY Change -200.82% -22.39% 1193.04%
Pretax Income $12.30M $10.20M $10.18M
YoY Change 6.83% 0.2% 626.78%
Income Tax $200.0K $175.1K $18.28K
% Of Pretax Income 1.63% 1.72% 0.18%
Net Earnings $12.14M $10.03M $10.16M
YoY Change 6.9% -1.35% 625.47%
Net Earnings / Revenue 75.38% 59.56% 58.45%
Basic Earnings Per Share $0.59 $0.49 $0.53
Diluted Earnings Per Share $0.59 $0.49 $0.52
COMMON SHARES
Basic Shares Outstanding 20.46M shares 20.49M shares 19.32M
Diluted Shares Outstanding 20.32M shares 20.49M shares 19.59M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $82.08M $80.61M $63.62M
YoY Change 80.06% 26.71% -49.83%
Cash & Equivalents $82.08M $80.61M $63.62M
Short-Term Investments
Other Short-Term Assets $697.9K $420.2K $604.2K
YoY Change 12.57% -30.46% -45.07%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $82.78M $81.03M $64.22M
YoY Change 79.16% 26.17% -50.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $371.2M $366.8M $389.8M
YoY Change -10.14% -5.91% 320.98%
TOTAL ASSETS
Total Short-Term Assets $82.78M $81.03M $64.22M
Total Long-Term Assets $371.2M $366.8M $389.8M
Total Assets $454.0M $447.8M $454.1M
YoY Change -1.15% -1.37% 104.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.284M $1.611M $1.616M
YoY Change 30.14% -0.28% 303.95%
Accrued Expenses $6.576M $8.698M $7.771M
YoY Change -43.08% 11.93% 72.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.70M $21.80M $20.27M
YoY Change 8.58% 7.57% 289.78%
LONG-TERM LIABILITIES
Long-Term Debt $87.71M $87.57M $96.66M
YoY Change -9.41% -9.41%
Other Long-Term Liabilities $259.2K $585.8K $629.2K
YoY Change -56.43% -6.89% 109.73%
Total Long-Term Liabilities $87.97M $88.15M $97.29M
YoY Change -9.7% -9.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.70M $21.80M $20.27M
Total Long-Term Liabilities $87.97M $88.15M $97.29M
Total Liabilities $113.7M $110.0M $117.6M
YoY Change -6.12% -6.47% 2172.15%
SHAREHOLDERS EQUITY
Retained Earnings -$9.103M -$11.41M
YoY Change 481.42%
Common Stock $204.6K $204.9K
YoY Change 3.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $340.3M $337.9M $336.5M
YoY Change
Total Liabilities & Shareholders Equity $454.0M $447.8M $454.1M
YoY Change -1.15% -1.37% 104.99%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $12.14M $10.03M $10.16M
YoY Change 6.9% -1.35% 625.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $5.146M $4.383M $4.665M
YoY Change -51.27% -6.06% 96.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $8.034M $14.99M -$30.05M
YoY Change -142.12% -149.89% 336.11%
Cash From Investing Activities $8.034M $14.99M -$30.05M
YoY Change -142.12% -149.89% 336.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.71M -$79.14M -20.25M
YoY Change 23.0% 290.85% -116.64%
NET CHANGE
Cash From Operating Activities 5.146M $4.383M 4.665M
Cash From Investing Activities 8.034M $14.99M -30.05M
Cash From Financing Activities -11.71M -$79.14M -20.25M
Net Change In Cash 1.474M -$59.77M -45.63M
YoY Change -108.17% 30.98% -138.94%
FREE CASH FLOW
Cash From Operating Activities $5.146M $4.383M $4.665M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001822523
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 afcg Severance Costs Period To Receive Base Salary
SeveranceCostsPeriodToReceiveBaseSalary
P12M
CY2023Q1 afcg Severance Cobra Premiums Paid Period
SeveranceCOBRAPremiumsPaidPeriod
P12M
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension
P1Y
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39995
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AFC GAMMA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1807125
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
525 Okeechobee Blvd., Suite 1650
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
West Palm Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33401
CY2023Q1 dei City Area Code
CityAreaCode
561
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
510-2390
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
AFCG
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
284500000 usd
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20456538 shares
CY2023Q1 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
102811826 usd
CY2022Q4 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
100635985 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99924201 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2023Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
275211195 usd
CY2022Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
285177112 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
2220653 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2220653 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
14408793 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13538077 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
263023055 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
273859688 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80605744 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
140372841 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
3860493 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
5257475 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
420155 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
460844 usd
CY2023Q1 us-gaap Assets
Assets
447833648 usd
CY2022Q4 us-gaap Assets
Assets
519176899 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1690334 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3200944 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2217083 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1036667 usd
CY2023Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
20031 usd
CY2022Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
18146 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11473971 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
11403840 usd
CY2023Q1 us-gaap Financing Receivable Covered Allowance For Credit Loss
FinancingReceivableCoveredAllowanceForCreditLoss
585838 usd
CY2022Q4 us-gaap Financing Receivable Covered Allowance For Credit Loss
FinancingReceivableCoveredAllowanceForCreditLoss
754128 usd
CY2023Q1 us-gaap Management Fee Payable
ManagementFeePayable
3704219 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
3891734 usd
CY2023Q1 afcg Accrued Direct Administrative Expenses
AccruedDirectAdministrativeExpenses
1086027 usd
CY2022Q4 afcg Accrued Direct Administrative Expenses
AccruedDirectAdministrativeExpenses
1843652 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1611267 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
836642 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
87565548 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
97131777 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
60000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
109954318 usd
CY2022Q4 us-gaap Liabilities
Liabilities
180117530 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
125 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
125 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
125 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
125 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20489234 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20489234 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20364000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20364000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
204892 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
203640 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
349085320 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
348817914 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11410883 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9962186 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
337879330 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
339059369 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
447833648 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
519176899 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
18500486 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296600000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
18635853 usd
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1668160 usd
CY2022Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1700115 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16832326 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16935738 usd
CY2023Q1 afcg Accrued Exchange Fee Rebate
AccruedExchangeFeeRebate
478645 usd
CY2022Q1 afcg Accrued Exchange Fee Rebate
AccruedExchangeFeeRebate
387493 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3704219 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3847213 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2006135 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1144444 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
280578 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
990023 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
420898 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
399368 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
6411830 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
6381048 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
702426 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
905129 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-26384 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
450000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1986381 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1477691 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
80843 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10200376 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10180404 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175102 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18284 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10162120 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20303797 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19319993 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20489163 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19591472 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10162120 usd
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
168750 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
168750 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10025274 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10330870 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
339059369 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
268658 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11473971 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
337879330 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
273075174 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
62972943 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
990023 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.55
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10858617 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
168750 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10162120 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
336510393 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10162120 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
702426 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
905129 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-26384 usd
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
450000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1986381 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1477691 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
80843 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1236946 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3965878 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
268658 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
990023 usd
CY2023Q1 afcg Payment In Kind Interest
PaymentInKindInterest
4503746 usd
CY2022Q1 afcg Payment In Kind Interest
PaymentInKindInterest
1618761 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1409750 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-177673 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1431 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-373765 usd
CY2023Q1 afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
3010610 usd
CY2022Q1 afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
4175108 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1180416 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1417883 usd
CY2023Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-187515 usd
CY2022Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
1024169 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-757625 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-417740 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
776510 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
109954 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4382627 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4665347 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
1523332 usd
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
50463213 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13693481 usd
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
0 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
2821467 usd
CY2022Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
20415460 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14991616 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30047753 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63939722 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
966779 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11403840 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8221406 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
7737500 usd
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
60000000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
75000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-79141340 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20248463 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-59767097 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-45630869 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140372841 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109246048 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80605744 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63615179 usd
CY2023Q1 afcg Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
1500000 usd
CY2022Q1 afcg Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
0 usd
CY2023Q1 afcg Original Issue Discount Withheld From Funding Of Loans
OriginalIssueDiscountWithheldFromFundingOfLoans
0 usd
CY2022Q1 afcg Original Issue Discount Withheld From Funding Of Loans
OriginalIssueDiscountWithheldFromFundingOfLoans
1067675 usd
CY2023Q1 afcg Proceeds From Sale Of Loans Receivable Not Yet Received
ProceedsFromSaleOfLoansReceivableNotYetReceived
0 usd
CY2022Q1 afcg Proceeds From Sale Of Loans Receivable Not Yet Received
ProceedsFromSaleOfLoansReceivableNotYetReceived
10600000 usd
CY2023Q1 afcg Proceeds From Sale Of Available For Sale Securities Not Yet Received
ProceedsFromSaleOfAvailableForSaleSecuritiesNotYetReceived
0 usd
CY2022Q1 afcg Proceeds From Sale Of Available For Sale Securities Not Yet Received
ProceedsFromSaleOfAvailableForSaleSecuritiesNotYetReceived
15900000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
168750 usd
CY2023Q1 afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
11473971 usd
CY2022Q1 afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
10858617 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
290834 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
69271 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P1Y
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
CY2023Q1 afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
3 loan
CY2022 afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
3 loan
CY2023Q1 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
104300000 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
104300000 usd
CY2023Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
104200000 usd
CY2022Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
102400000 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Funded Of Outstanding Principal
LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal
800000 usd
CY2023Q1 afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue
0 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99924201 usd
CY2023Q1 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
102811826 usd
CY2023Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
104172301 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2022Q4 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
100635985 usd
CY2022Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
102376546 usd
CY2022 afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P1Y2M12D
CY2022Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
102376546 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
1740561 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-1409934 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-1477691 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-1477691 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Outstanding Principal New Fundings
LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings
802884 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value New Funding
LoansHeldForInvestmentAtFairValueNewFunding
802884 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount
380086 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount
380086 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest
LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest
992871 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Payment In Kind Interest
LoansHeldForInvestmentAtFairValuePaymentInKindInterest
992871 usd
CY2023Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
104172301 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
1360475 usd
CY2023Q1 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-2887625 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99924201 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99924201 usd
CY2023Q1 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
102811826 usd
CY2023Q1 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
104172301 usd
CY2022 afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
9 loan
CY2023Q1 afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
9 loan
CY2023Q1 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
313100000 usd
CY2022Q4 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
338900000 usd
CY2023Q1 afcg Loans Held For Investment At Carrying Value Outstanding Principal New Fundings
LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings
2200000 usd
CY2023Q1 afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
15000000 usd
CY2023Q1 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.77
CY2022Q4 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.73
CY2023Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
284494385 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
9283190 usd
CY2023Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
275211195 usd
CY2023Q1 afcg Loans Held For Investment Weighted Average Remaining Life
LoansHeldForInvestmentWeightedAverageRemainingLife
P2Y10M24D
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296584529 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11407417 usd
CY2022Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
285177112 usd
CY2022 afcg Loans Held For Investment Weighted Average Remaining Life
LoansHeldForInvestmentWeightedAverageRemainingLife
P3Y1M6D
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296584529 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11407417 usd
CY2022Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
285177112 usd
CY2023Q1 afcg Receivable With Imputed Interest New Funding Face Amount
ReceivableWithImputedInterestNewFundingFaceAmount
2220448 usd
CY2023Q1 afcg Receivable With Imputed Interest New Funding Net Amount
ReceivableWithImputedInterestNewFundingNetAmount
2220448 usd
CY2023Q1 afcg Receivable With Accretion Of Original Issue Discount Premium
ReceivableWithAccretionOfOriginalIssueDiscountPremium
856860 usd
CY2023Q1 afcg Accretion Of Original Issue Discount Net Amount
AccretionOfOriginalIssueDiscountNetAmount
856860 usd
CY2023Q1 afcg Receivable With Imputed Interest Loan Repayments Face Amount
ReceivableWithImputedInterestLoanRepaymentsFaceAmount
998142 usd
CY2023Q1 afcg Receivable With Imputed Interest Loan Repayments
ReceivableWithImputedInterestLoanRepayments
998142 usd
CY2023Q1 afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
15000000 usd
CY2023Q1 afcg Receivable With Imputed Interest Sale Of Loans Original Issue Discount
ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount
-1267367 usd
CY2023Q1 afcg Receivable With Sale Of Loans Net Amount
ReceivableWithSaleOfLoansNetAmount
13732633 usd
CY2023Q1 afcg Receivable With Paid In Kind Interest Face Amount
ReceivableWithPaidInKindInterestFaceAmount
3510875 usd
CY2023Q1 afcg Receivable With Paid In Kind Interest Net Amount
ReceivableWithPaidInKindInterestNetAmount
3510875 usd
CY2023Q1 afcg Receivable With Imputed Interest Amortization Payments
ReceivableWithImputedInterestAmortizationPayments
1823325 usd
CY2023Q1 afcg Receivable With Imputed Interest Loan Amortization Payments
ReceivableWithImputedInterestLoanAmortizationPayments
1823325 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
284494385 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
9283190 usd
CY2023Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
275211195 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
284494385 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
9283190 usd
CY2023Q1 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
275211195 usd
CY2023Q1 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2022Q4 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2022Q4 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2023Q1 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2023Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2200000 usd
CY2022Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2200000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
0 usd
CY2022Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2222339 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
1686 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2220653 usd
CY2023Q1 afcg Accretion Of Original Issue Discount
AccretionOfOriginalIssueDiscount
0 usd
CY2023Q1 afcg Accretion Of Original Issue Discount At Carrying Value
AccretionOfOriginalIssueDiscountAtCarryingValue
0 usd
CY2023Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2222339 usd
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
1686 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
2220653 usd
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
69364769 usd
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
184393671 usd
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
23673408 usd
CY2023Q1 afcg Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss
LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss
277431848 usd
CY2023Q1 afcg Interest Receivables
InterestReceivables
2317982 usd
CY2022Q4 afcg Interest Receivables
InterestReceivables
3722134 usd
CY2023Q1 afcg Payment In Kind Receivable
PaymentInKindReceivable
1501100 usd
CY2022Q4 afcg Payment In Kind Receivable
PaymentInKindReceivable
1409678 usd
CY2023Q1 afcg Unused Fees Receivable
UnusedFeesReceivable
41411 usd
CY2022Q4 afcg Unused Fees Receivable
UnusedFeesReceivable
125663 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
3860493 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
5257475 usd
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
61500000 usd
CY2023Q1 afcg Number Of Loans Included In Loan Funded Interest Reserve
NumberOfLoansIncludedInLoanFundedInterestReserve
1 loan
CY2022 afcg Number Of Loans Included In Loan Funded Interest Reserve
NumberOfLoansIncludedInLoanFundedInterestReserve
3 loan
CY2023Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
3200000 usd
CY2022Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
4200000 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3200944 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4782271 usd
CY2023Q1 afcg New Reserves Interest
NewReservesInterest
1716985 usd
CY2022Q1 afcg New Reserves Interest
NewReservesInterest
0 usd
CY2023Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
3227595 usd
CY2022Q1 afcg Reserves Disbursed Interest
ReservesDisbursedInterest
4175108 usd
CY2023Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1690334 usd
CY2022Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
607163 usd
CY2022Q2 afcg Line Of Credit Facility Accordion Feature Increase Limit
LineOfCreditFacilityAccordionFeatureIncreaseLimit
100000000.0 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1435417 usd
CY2023Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
35833 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
196910 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1668160 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1441321 usd
CY2022Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
45833 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
212961 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1700115 usd
CY2023Q1 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
421357243 usd
CY2022Q4 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
447101864 usd
CY2023Q1 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
389499749 usd
CY2022Q4 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
401476418 usd
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
31857494 usd
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
45625446 usd
CY2023Q1 afcg Severance Cobra Premiums Paid Percentage
SeveranceCOBRAPremiumsPaidPercentage
1
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches
1 tranche
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
700000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3000000 shares
CY2022Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
20.50
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3291832 shares
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
67500000 usd
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
63000000.0 usd
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
232489 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
293420 shares
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2142143 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2081212 shares
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
88749 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
88749 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1604236 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
742000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.46
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25130 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.98
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2321106 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175100 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
10025274 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10162120 usd
CY2023Q1 us-gaap Dividends
Dividends
35472 usd
CY2022Q1 us-gaap Dividends
Dividends
28143 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9989802 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9989802 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10133977 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18300 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10133977 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20303797 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19319993 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
185366 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
271479 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20489163 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19591472 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2280372 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
742000 shares
CY2023Q1 afcg Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains
ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains
0.04
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99924201 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99924201 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99226051 usd
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
200000 usd
CY2023Q1 afcg Incentive Compensation
IncentiveCompensation
2800000 usd
CY2022Q1 afcg Incentive Compensation
IncentiveCompensation
3000000.0 usd
CY2023Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1347685 usd
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1255867 usd
CY2023Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
478645 usd
CY2022Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
387493 usd
CY2023Q1 afcg Related Party Transaction Base Management Fees Net
RelatedPartyTransactionBaseManagementFeesNet
869040 usd
CY2022Q1 afcg Related Party Transaction Base Management Fees Net
RelatedPartyTransactionBaseManagementFeesNet
868374 usd
CY2023Q1 afcg Incentive Compensation
IncentiveCompensation
2835179 usd
CY2022Q1 afcg Incentive Compensation
IncentiveCompensation
2978839 usd
CY2023Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
1086027 usd
CY2022Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
906717 usd
CY2023Q1 us-gaap Related Party Costs
RelatedPartyCosts
4790246 usd
CY2022Q1 us-gaap Related Party Costs
RelatedPartyCosts
4753930 usd
CY2023Q1 afcg Number Of Co Invested Loans Held
NumberOfCoInvestedLoansHeld
4 loan

Files In Submission

Name View Source Status
afcg-20230331_pre.xml Edgar Link unprocessable
afcg-20230331_cal.xml Edgar Link unprocessable
afcg-20230331_def.xml Edgar Link unprocessable
0001822523-23-000012-index-headers.html Edgar Link pending
0001822523-23-000012-index.html Edgar Link pending
0001822523-23-000012.txt Edgar Link pending
0001822523-23-000012-xbrl.zip Edgar Link pending
afcg-20230331.htm Edgar Link pending
afcg-20230331.xsd Edgar Link pending
afcg-20230331xex311.htm Edgar Link pending
afcg-20230331xex312.htm Edgar Link pending
afcg-20230331xex321.htm Edgar Link pending
afcg-20230331xex322.htm Edgar Link pending
afcg-20230331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
afcg-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
afcg-20230331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending